Evidence map›Paper›PMID 38016764›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Expert consensus on MRI diagnosis of liver fibrosis in chronic hepatitis B (version 2023)].

Radiology Committee on Infectious and Inflammatory Disease, Chinese Research Hospital Association;, Radiology of Infection Sub-branch, Radiology Branch, Chinese Medical Association;, Digital Health Committee of China Association for the Promotion of Science and Technology Industrialization;, Committee on Radiology of HIV, Working and Treating Committee of HIV/AIDS and STD Association;, Radiology of Infectious Disease Management Sub-branch, Infectious Disease Management Branch, Hospital Management Association in China;, Beijing Imaging Diagnosis and Treatment Technology Innovation Alliance

Abstract readEnglish AbstractConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Radiology Committee on Infectious and Inflammatory Disease, Chinese Research Hospital Association;
Radiology of Infection Sub-branch, Radiology Branch, Chinese Medical Association;
Digital Health Committee of China Association for the Promotion of Science and Technology Industrialization;
Committee on Radiology of HIV, Working and Treating Committee of HIV/AIDS and STD Association;
Radiology of Infectious Disease Management Sub-branch, Infectious Disease Management Branch, Hospital Management Association in China;
Beijing Imaging Diagnosis and Treatment Technology Innovation Alliance

Funding

Shanghai Hospital Development Center SHDC12019128
6 · The paper itself

Abstract

Chronic hepatitis B is a common chronic inflammatory disease of the liver in China that frequently results in sustained damage to the liver parenchyma, followed by liver fibrosis, and ultimately progresses to unfavorable outcomes such as cirrhosis, liver failure, and liver cancer. Liver fibrosis reversal can be achieved through early and effective intervention. Therefore, timely and accurate assessment of the degree of liver fibrosis is of great clinical significance for the treatment and prognosis assessment of patients with chronic hepatitis B. MRI plays a crucial role in the early assessment and monitoring of the therapeutic efficacy of liver fibrosis in chronic hepatitis B. Currently, there is a lack of uniform consensus on MRI scanning protocols and related diagnostic thresholds for liver fibrosis in chronic hepatitis B, which is not conducive to practical clinical evaluation and application. This expert consensus is based on a full review of relevant domestic and international literature and the formulation of methodologies based on evidence-based medical guidelines and standards to develop recommendations for MRI scanning techniques and the diagnosis of liver fibrosis in chronic hepatitis B, with a view to providing a clear basis for the clinical diagnosis.

Indexed as

Hepatitis B, ChronicHumansLiverLiver CirrhosisMagnetic Resonance ImagingChronic hepatitis BExpert consensusHepatic fibrosisMagnetic resonance imaging

Identifiers

PMID38016764
PMCPMC12869180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.